For example, miRNA-126 within EVs may predict DKD pathogenesis and serve as a marker of therapeutic intervention effects [16,17] owing to the regulatory role of miRNA-126 in the response to VEGF (an essential factor in the pathogenesis of DKD). This evidence concerns the gene VEGFA and diabetic kidney disease.